Cutoff values for the diagnosis of sarcopenia in pre-liver transplant patients

Tiago Cabral, Luís Henrique Telles da Rosa, Claudio Augusto Marroni, Lucas Homercher Galant, André Ferreira D'Avila, Kally Janaina Berleze, José Leonardo Faustini Pereira, Danusa Rossi

Abstract


58 anos) e modelo para doença hepática final de 12 pontos; houve predominância de homens. A etiologia mais comum (60,4%) foi o vírus da hepatite C. Os valores de corte foram MAMC ≤ 25,09 cm para a massa muscular, PT ≤ 93,4 Nm para a força muscular e 6MWT ≤ 459 m para a função muscular. e as precisões usadas para determinar a massa muscular, força e função pelo MAMC, PT e 6MWT foram ≤ 25,09 cm e 77,9%, ≤ 93,4Nm e 72,72% e ≤ 459 me 75%, respectivamente.

Keywords


Diagnosis; Sarcopenia; Body composition; Liver transplant.

References


Krüger RL, Teixeira BC, Dias AS, Reischak-Oliveira Á. The influence that hepatic cirrhosis provides in exercise capacity and muscle strength: a review. Fisioterapia em Movimento. 2015 Sep;28(3):617–25. DOI: 10.1590/0103-5150.028.003.AR02.

Nishikawa H, Osaki Y. Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators of Inflammation. 2015;2015:1–9. DOI: 10.1155/2015/872152.

Kim HY. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score. World Journal of Gastroenterology. 2015;21(25):7637. DOI: 10.3748/wjg.v21.i25.7637.

Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study: Liver Failure/Cirrhosis/Portal Hypertension. Hepatology. 2016 Feb;63(2):574–80. DOI: 10.1002/hep.28316.

Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. Journal of Hepatology. 2016 Dec;65(6):1232–44. DOI: 10.1016/j.jhep.2016.07.040.

Ponziani FR, Gasbarrini A. Sarcopenia in Patients with Advanced Liver Disease. Curr Protein Pept Sci. 2018;19(7):681–91. DOI: 10.2174/1389203718666170428121647.

Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions. Alimentary Pharmacology & Therapeutics. 2016 Apr;43(7):765–77. DOI: 10.1111/apt.13549.

Kang SH, Kim MY, Baik SK. The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis. J Korean Med Sci [Internet]. 2018 Dec 3 [cited 2019 Oct 27];33(50). DOI: 10.3346/jkms.2018.33.e334.

Xiao HJ, Zhang M, Qi YM, Han T. [Research advances of sarcopenia in chronic liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2019 Jul 20;27(7):563–6. DOI: 10.3760/cma.j.issn.1007-3418.2019.07.018.

Jeong JY, Lim S, Sohn JH, Lee JG, Jun DW, Kim Y. Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis. J Korean Med Sci [Internet]. 2018 Oct 31 [cited 2019 Oct 27];33(50). DOI: 10.3346/jkms.2018.33.e299.

Van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ and Ijzermans JNM. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. J Hepatol. 2018;68(4):707–14. DOI: 10.1016/j.jhep.2017.11.030.

van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, Polak WG, Metselaar HJ and IJzermans JNM. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int. 2018;31(2):165–74. DOI: 10.1111/tri.13048.

Kallwitz ER. Sarcopenia and liver transplant: The relevance of too little muscle mass. World Journal of Gastroenterology. 2015;21(39):10982. DOI: 10.3748/wjg.v21.i39.10982.

Rosenberg IH. Summary comments. Am J Clin Nutr. 1989 Nov 1;50(5):1231-3. DOI: 10.1093/ajcn/50.5.1231.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010 Jul;39(4):412–23. DOI: 10.1093/ageing/afq034.

Bera TK. Bioelectrical Impedance Methods for Noninvasive Health Monitoring: A Review. Journal of Medical Engineering. 2014;2014:1–28. DOI: 10.1155/2014/381251.

Cornet M, Lim C, Salloum C, Lazzati A, Compagnon P, Pascal G and Azoulay D. Prognostic value of sarcopenia in liver surgery. Journal of Visceral Surgery. 2015 Nov;152(5):297-304. DOI: 10.1016/j.jviscsurg.2015.08.001.

Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RAF and Kim WR. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001 Jul;7(7):567–80. DOI: 10.1016/j.jviscsurg.2015.08.001.

Perkins JD, Halldorson JB, Bakthavatsalam R, Fix OK, Carithers RL, Reyes JD. Should liver transplantation in patients with model for end-stage liver disease scores

ATS Statement: Guidelines for the Six-Minute Walk Test. American Journal of Respiratory and Critical Care Medicine. 2002 Jul;166(1):111–7. DOI: 10.1164/ajrccm.166.1.at1102.

Canda AS. Puntos de corte de diferentes parámetros antropométricos para el diagnóstico de sarcopenia. Nutrición Hospitalaria, 32(2), 765-770. DOI: 10.3305/nh.2015.32.2.9193.

F. Wiesinger, Michael Quittan, Kari G. Physical performance and health-related quality of life in men on a liver transplantation waiting list. Journal of Rehabilitation Medicine. 2001 Nov 1;33(6):260–5. DOI: 10.1080/165019701753236446.

Soares MR, Pereira CA de C. Teste de caminhada de sei.s minutos: valores de referência para adultos saudáveis no Brasil. Jornal Brasileiro de Pneumologia. 2011 Oct;37(5):576–83. DOI: 10.1590/S1806-37132011000500003.

dos Santos DC, Limongi V, de Oliveira da Silva AM, de Ataide EC, Trovato Mei MF, Udo EY, Boin IF and Stucchi RS. Evaluation of Functional Status, Pulmonary Capacity, Body Composition, and Quality of Life of End-Stage Liver Disease Patients Who are Candidates for Liver Surgery. Transplantation Proceedings. 2014 Jul;46(6):1771–4. DOI: 10.1016/j.transproceed.2014.05.043.

Galant LH, Forgiarini Junior LA, Dias AS, Marroni CA. Condição funcional, força muscular respiratória e qualidade de vida em pacientes cirróticos. Brazilian Journal of Physical Therapy. 2012 Feb;16(1):30–4. DOI: 10.1590/S1413-35552012000100006.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 01;48(1):16–31. DOI: 10.1093/ageing/afy169.

Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE and Douglas DD. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transplantation. 2010 Dec;16(12):1373–8. DOI: 10.1002/lt.22167.

Román E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, Bascuñana H, Juárez C, Guarner C, Córdoba J and Soriano G. Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis. Dig Dis Sci. 2014 Aug 1;59(8):1966–75. DOI: 10.1007/s10620-014-3086-6.

Mizuno Y, Ito S, Hattori K, Nagaya M, Inoue T, Nishida Y, Onishi Y, Kamei H, Kurata N, Hasegawa Y and Ogura Y. Changes in Muscle Strength and Six-Minute Walk Distance Before and After Living Donor Liver Transplantation. Transplantation Proceedings. 2016 Dec;48(10):3348–55. DOI: 10.1016/j.transproceed.2016.08.042.

Yadav A, Chang Y-H, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE and Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015 Feb;29(2):134–41. DOI: 10.1111/ctr.12493.

Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, Ma M, Abraldes JG, Paterson I, Haykowsky MJ and Tandon P. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1920-1926.e2. DOI: 10.1016/j.cgh.2014.04.016.

Dourado VZ. Equações de referência para o teste de caminhada de seis minutos em indivíduos saudáveis. Arquivos Brasileiros de Cardiologia. 2011 Jun;96(6):e128–38. DOI: 10.1590/S0066-782X2011005000024.

Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, Lucidi C, Di Martino M, Catalano C and Merli M. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. European Journal of Gastroenterology & Hepatology. 2015 Mar;27(3):328–34. DOI: 10.1097/MEG.0000000000000274.

Paciocco G, Martinez FJ, Bossone E, Pielsticker E, Gillespie B, Rubenfire M. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. European Respiratory Journal. 2001 Apr 1;17(4):647–52. DOI: 10.1183/09031936.01.17406470.

Bering T, Diniz KGD, Coelho MPP, Vieira DA, Soares MMS, Kakehasi AM, Correia MITD, Teixeira R, Queiroz DMM, Rocha GA and Silva LD. Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C: Sarcopenia and bone mineral density in hepatitis C. Journal of Cachexia, Sarcopenia and Muscle. 2018 Apr;9(2):255–68. DOI: 10.1002/jcsm.12269.

Oliveira CMC de, Kubrusly M, Mota RS, Silva CAB da, Oliveira VN. Desnutrição na insuficiência renal crônica: qual o melhor método diagnóstico na prática clínica? Jornal Brasileiro de Nefrologia. 2010 Mar;32(1):57–70. DOI: 10.1590/S0101-28002010000100011.

Andersen H, Borre M, Jakobsen J, Andersen PH, Vilstrup H. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology. 1998 May;27(5):1200–6. DOI: 10.1002/hep.510270503.

Gadelha AB, Dutra MT, Oliveira RJ de, Safons MP, Lima RM. Associação entre força, sarcopenia e obesidade sarcopénica com o desempenho funcional de idosas. Motricidade. 2014 Sep 1;10(3). DOI: 10.6063/motricidade.10(3).2775.

Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, Esfandiari N, Baracos V, Montano-Loza AJ and Myers RP. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value. Liver Transplantation. 2012 Oct;18(10):1209–16. DOI: 10.1002/lt.23495.

Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014 Jul 7;20(25):8061–71. DOI: 10.3748/wjg.v20.i25.8061.

Tachi Y, Kozuka A, Hirai T, Ishizu Y, Honda T, Kuzuya T, Hayashi K, Ishigami M and Goto H. Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease. Journal of Gastroenterology and Hepatology. 2018;33(9):1659–66. DOI: 10.1111/jgh.14133.

Carias S, Castellanos AL, Vilchez V, Nair R, Dela Cruz AC, Watkins J, Barrett T, Trushar P, Esser K and Gedaly R. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation: Sarcopenic obesity in patients with cirrhosis. Journal of Gastroenterology and Hepatology. 2016 Mar;31(3):628–33. DOI: 10.1111/jgh.13166.

Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: Abnormalities and implications. Journal of Gastroenterology and Hepatology. 2015;30(2):244–51. DOI: 10.1111/jgh.12695.

Moctezuma-Velázquez C, Low G, Mourtzakis M, Ma M, Burak KW, Tandon P and Montano-Loza AJ. Association between Low Testosterone Levels and Sarcopenia in Cirrhosis: A Crosssectional Study. Ann Hepatol. 2018 Aug;17(4):615–23. DOI: 10.5604/01.3001.0012.0930.

Hayashi F, Matsumoto Y, Momoki C, Yuikawa M, Okada G, Hamakawa E, Kawamura E, Hagihara A, Toyama M, Fujii H, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Kawada N and Habu D. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis: Sarcopenia in compensated liver cirrhosis. Hepatology Research. 2013 Dec;43(12):1264–75. DOI: 10.1111/hepr.12085.

Tsien C, Garber A, Narayanan A, Shah SN, Barnes D, Eghtesad B, Fung J, McCullough AJ and Dasarathy S. Post-liver transplantation sarcopenia in cirrhosis: A prospective evaluation: Post-liver transplant sarcopenia. Journal of Gastroenterology and Hepatology. 2014 Jun;29(6):1250–7. DOI: 10.1111/jgh.12524.


Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.